Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01685411
Title Busulfan and Cyclophosphamide Followed By ALLO BMT
Recruitment Terminated
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

Therapies

Busulfan + Cyclophosphamide

Filgrastim

Allopurinol

Mycophenolate mofetil

anti-thymocyte globulin

Tacrolimus

Levetiracetam

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.